Rheumatologists‘ recommendations on what to do in the dermatology office to evaluate and manage psoriasis patients’ joint symptoms. J. Dermatol. […]
… Rheumatology Unit, University of Verona in Verona, Italy. It was published online on December 1, 2025, in Arthritis &
Arterioscler Thromb Vasc Biol. 2025 Dec 18. doi: 10.1161/ATVBAHA.125.323111. Online ahead of print. ABSTRACT Sarcoidosis is a chronic inflammatory disease
Autoimmunity. 2025 Dec;58(1):2445537. doi: 10.1080/08916934.2024.2445537. Epub 2024 Dec 29. ABSTRACT To examine the differences in the proportions of circulating peripheral
J Rheum Dis. 2026 Jan 1;33(1):19-24. doi: 10.4078/jrd.2025.0077. Epub 2025 Aug 19. ABSTRACT Axial spondyloarthritis (axSpA) is a chronic inflammatory
J Rheum Dis. 2026 Jan 1;33(1):25-36. doi: 10.4078/jrd.2025.0055. Epub 2025 May 30. ABSTRACT OBJECTIVE: We aimed to identify predictors of
J Rheum Dis. 2026 Jan 1;33(1):7-18. doi: 10.4078/jrd.2025.0034. Epub 2025 Oct 21. ABSTRACT Rheumatoid arthritis (RA) is a chronic, systemic
J Rheum Dis. 2026 Jan 1;33(1):1-2. doi: 10.4078/jrd.2025.0148. Epub 2025 Oct 28. NO ABSTRACT PMID:41409810 | PMC:PMC12706434 | DOI:10.4078/jrd.2025.0148
J Rheum Dis. 2026 Jan 1;33(1):37-45. doi: 10.4078/jrd.2025.0056. Epub 2025 Sep 1. ABSTRACT OBJECTIVE: The aim of this meta-analysis was
J Rheum Dis. 2026 Jan 1;33(1):46-54. doi: 10.4078/jrd.2025.0070. Epub 2025 Aug 26. ABSTRACT OBJECTIVE: To examine the risk of cardiovascular
J Rheum Dis. 2026 Jan 1;33(1):55-64. doi: 10.4078/jrd.2025.0074. Epub 2025 Jul 22. ABSTRACT OBJECTIVE: Interferon (IFN) signaling, and excessive apoptosis
J Rheum Dis. 2026 Jan 1;33(1):65-69. doi: 10.4078/jrd.2025.0019. Epub 2025 Apr 3. ABSTRACT Janus kinase inhibitors (JAKis) are associated with
J Rheum Dis. 2026 Jan 1;33(1):3-6. doi: 10.4078/jrd.2025.0010. Epub 2025 Apr 21. ABSTRACT Posterior reversible encephalopathy syndrome (PRES) is a
Can J Pain. 2025 Dec 15;9(1):2583909. doi: 10.1080/24740527.2025.2583909. eCollection 2025. ABSTRACT Patients with chronic pain that cannot be explained by
Front Immunol. 2025 Dec 2;16:1700737. doi: 10.3389/fimmu.2025.1700737. eCollection 2025. ABSTRACT OBJECTIVE: VEXAS syndrome (Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic) is
Ther Adv Musculoskelet Dis. 2025 Dec 14;17:1759720X251405094. doi: 10.1177/1759720X251405094. eCollection 2025. NO ABSTRACT PMID:41409115 | PMC:PMC12705982 | DOI:10.1177/1759720X251405094
Eur J Haematol. 2025 Dec 18. doi: 10.1111/ejh.70085. Online ahead of print. ABSTRACT Allogeneic hematopoietic stem cell transplantation (HSCT) is
Adding romosozumab to ongoing denosumab treatment shows increased lumbar spine bone mineral density with preserved anabolic effect in postmenopausal women
Patients with eosinophilic granulomatosis with polyangiitis who received 2 years of treatment with the interleukin-5 inhibitor benralizumab exhibited durable remission
Together with a group of Oxford researchers, Mark Coles, Professor of Immunology at the Kennedy Institute, will co-lead the Enabling
BMC Nephrol. 2025 Dec 17. doi: 10.1186/s12882-025-04695-y. Online ahead of print. NO ABSTRACT PMID:41408511 | DOI:10.1186/s12882-025-04695-y
Int J Rheum Dis. 2025 Dec;28(12):e70511. doi: 10.1111/1756-185x.70511. ABSTRACT AIM: EULAR recommendations for the role of nurses in managing chronic
Cell Death Differ. 2025 Dec 17. doi: 10.1038/s41418-025-01637-x. Online ahead of print. ABSTRACT Repair of DNA double-strand breaks (DSBs) is
Rheumatology (Oxford). 2025 Dec 17:keaf687. doi: 10.1093/rheumatology/keaf687. Online ahead of print. NO ABSTRACT PMID:41408380 | DOI:10.1093/rheumatology/keaf687
ACR Open Rheumatol. 2025 Dec;7(12):e70151. doi: 10.1002/acr2.70151. NO ABSTRACT PMID:41408376 | DOI:10.1002/acr2.70151
BMC Psychol. 2025 Dec 17. doi: 10.1186/s40359-025-03855-x. Online ahead of print. ABSTRACT BACKGROUND: Artificial intelligence-based follow-up systems offer efficient solutions
Rheumatology (Oxford). 2025 Dec 17:keaf668. doi: 10.1093/rheumatology/keaf668. Online ahead of print. ABSTRACT OBJECTIVES: The interplay between the gut microbiome (GM),
